News

26 October 2021

BAP Pharma celebrates its 10th Anniversary

This month, BAP Pharma celebrated its 10th anniversary – marking 10 years since the company was first established in 2011.

We came together as a company to celebrate this amazing milestone in style, with a wonderful James Bond themed, formal event at the Oakley Court Hotel, Windsor.

After the lifting of COVID restrictions, it was wonderful to be able to bring the whole company together, to celebrate our success as a team and recognise everyone’s hard work and dedication, which has enabled the company to be successful.

Dr. Bashir Parkar and Nafisa Parkar, Directors of BAP Pharma

 

Our Beginning…

Beginning his career as a research scientist before progressing to the more commercial side of the pharmaceutical industry, Dr. Bashir Parkar made the decision to establish his own business, ‘BAP Pharma’, in 2011. He became a specialist supplier of comparators for clinical trials, that focused on delivering a high-quality service to his clients.

 

Where We Are Now…

BAP Pharma has continued to flourish, with significant growth and success, building a reputable, loyal client base.

2021 has seen BAP Pharma move into their new UK HQ office, based in Marlow. The new 24,000 sq. ft office marks a large investment by the business, in order to accommodate our growing headcount and business divisions expansion.

We have recently introduced two new divisions to complement our award-winning Comparator Sourcing Division.

Our Medicines Access Division, which will manage products at an early stage, pre-marketing or later stage, went live in Spring 2021 and our Packaging and Labelling division, based in a state-of-the-art facility in Bavaria, Germany, will go live Q4 2021.

 

Our Future…

With these two new divisions complementing our core comparator business, we are confident we will continue to post significant double-digit growth year on year. We are incredibly excited to see what the future holds for BAP Pharma.

 

“We are extremely proud to have achieved the 10-year milestone and this would not have been possible without the support and dedication from our loyal clients and our amazing staff over the years. This is a realisation of the vision I had 10 years ago, that our new facilities would reflect our clients. To achieve our turnover of £250M is exactly what I have envisaged and a fantastic achievement”.

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

 

[smartslider3 slider=”2″]

You Might Also Like

BAP Pharma awarded EcoVadis Silver Sustainability Rating

BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide. EcoVadis review more than 75,000 companies based on four main areas: Environment Labour & Human Rights Ethics

BAP Pharma awarded EcoVadis Silver Sustainability Rating

BAP Pharma Granted Secondary Packaging and Labelling Licence

BAP Pharma are pleased to announce that the Government of Upper Bavaria (Regierung von Oberbayern) have granted a Secondary Packaging and Labelling licence, to our German facility. The new licence will enable BAP Pharma to offer bespoke Clinical Trial Secondary Packaging and Labelling services, to complement our award-winning Comparator Sourcing

BAP Pharma Granted Secondary Packaging and Labelling Licence

BAP Pharma ranked in FEBE Growth 100 List

BAP Pharma are honoured to receive an award from FEBE Growth 100 and to have been ranked within the 2022 list of the fastest growing, founder-led, privately-owned UK businesses. BAP Pharma receiving the FEBE Growth 100 Award – pictured left to right – Award Partner Anthony Higson from Pictet, FEBE

BAP Pharma ranked in FEBE Growth 100 List